Marshall Wace North America’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
Other funds holding VTRS
DSA
LCM
DM
Marshall Wace North America's VTRS Position: Q3 2021 in Review
Marshall Wace North America reduced its Viatris (VTRS) stake by 15% in Q3 2021, selling an estimated $235K and leaving 93,079 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #848.
Marshall Wace North America first reported a position in VTRS in Q3 2013 and has held it in 8 quarters since. The position peaked at $17.7M in Q4 2019. 1,017 funds tracked by Wall St. Rank hold VTRS as of Q3 2021.
- Marshall Wace North America held 93,079 shares of Viatris worth $1.26M as of Q3 2021.
- Marshall Wace North America sold 16,590 Viatris shares in Q3 2021, an estimated $235K.
- Viatris made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #848 holding.
- Marshall Wace North America first reported a position in Viatris in Q3 2013 and has held it in 8 quarters since.
- Marshall Wace North America's Viatris position peaked at $17.7M in Q4 2019.
- 1,017 funds tracked by Wall St. Rank held Viatris as of Q3 2021.
Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.